載入...
Could valproic acid be an effective anticancer agent? The evidence so far
Valproic acid is an inhibitor of class I histone deacetylases. Epigenetic therapies in cancer have been focus of a keen interest and HDAC inhibitors in particular have been approved for certain types of hematologic malignancies. Valproic acid is an attractive candidate for cancer therapy due to its...
Na minha lista:
| 發表在: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4579528/ https://ncbi.nlm.nih.gov/pubmed/25017212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2014.940329 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|